论文信息 - Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma - 字舞流文

Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma

M. Mori | E. Epner | Yiyi Chen | D. Claxton | S. Spurgeon | E. Latour | J. Pu | F. LeBlanc | Z. Hasanali | Sara Shimko | K. Sharma | C. Ehmann | A. Stewart | N. Subbiah | G. Palmbach